Going to be a good call on Tuesday. We had new coverage this week with a price target of $3.
Earnings could be a big surprise because of the UTHR $45 million we received. MNKD definitely can recognize part of that payment if not the majority in the quarter. They may space it out over 4 quarters, but even then it could be a nice number that Wall Street isn't expecting.
Finally scrips were fine because it doesn't take into account the direct to consumer number. I'm sure that would add another 100-200 at minimum and could even be 500 at this point in time.
Lastly, volume has picked up along with the stock price. The warrants from the last offering could be exercised and bring in another $30+M in cash. We are good without those warrants on the cash front until the end of Q3.
I think next week we will see the drug pipeline updated as well on their web page as its been down for about two weeks. Big week coming up IMO. Have a good weekend and I think $2+ is realistic after call.
News 
Market Data 
Discover 
